!!!Adam Frederik Cohen
\\
%%(float:left;margin-left:20px;margin-right:30px;)
[{Image src='Cohen_Adam_Afbeelding1.png'  alt='Adam Frederik Cohen' height='220'}]
%%
[{AcadMemberDataPlugin}]
\\ \\
\\ \\
__Present and Previous Positions__
* 2018 - 2021 Research Director Innovation and Consultancy CHDR,Leiden
* 1999 - 2011 Vice chairman and chairman of the Netherlands Central Commission for Medical research (CCMO) and Clinical Trial Competent Authority
* 1993 - 2019 Professor of Clinical Pharmacology, Leiden University Medical Centre
* 2014 - 2019 Board member of Omnicomm Inc (OMCM Nasdaq). Member of audit committee and governance committee
* 1987 - 2018 CEO and sole statutory director Foundation Centre for Human Drug Research Leiden
* 2006 - 2013 CEO of Promasys BV a data management company in Leiden
* 1984 - 1987 European Project leader, Wellcome Research Laboratories, Beckenham, Kent and Research Registrar Department of Nephrology Dulwich Hospital, London, UK
* 1984 Senior house officer, Medicine and Nephrology, Dulwich Hospital, London.
* 1981 - 1984 Department of Clinical Pharmacology,Wellcome Research Laboratories Beckenham, Research physician
* 1980 - 1981 Pre-Registration clinical training 
\\
__Fields of Scholarship__
[{AcadMemberFOScholarshipPlugin}]
\\
__Honours and Awards__
*2021 DDCD Consultancy. Principal consultant
*2014 Member of the non-executive board of the Rotterdam Eye Hospital. (2014). Responsible for research and innovation.
*Chairman and founder of the Paul Janssen FutureLab a new school for scientific entrepeneurs established by the Ministry of Health of the Netherlands in association with Leiden University.
* Member of the scientific advisory board of the Netherlands Diabetes Patients Association
* Member of the Scientific Advisory Board of the German Aerospace Research Labs (DLR) Cologne
* Member of the Scientific Advisory Board of FACIO BV (NL)
* Member of the Review Board of the Swiss Nazional Fund (SNF) clinical trials program
* Scientific Advisory Board of the Drug Clinical Trial Center Peking University Third Hospital, Beijing, P.R.China
* Senior Advisor to the Board of the Foundation CHDR Leiden the Netherlands
* Officer in the Royal Order of Orange Nassau 
* Fellowship of the Faculty of Pharmaceutical Medicine of the Royal College of Medicine of the UK (FFPM)
*2009 Fellowship of the American College of Clinical Pharmacology (FCP)
* Fellowship of the British Pharmacological Society (FBPhS)
* Lilly Prize 2017 of the British Pharmacological Society 
*2021 Saal van Zwanenburg prize of the Royal Holland Society for Sciences (KHMVW) for drug development and entrepreneurship
\\
%%columns-900

%%coolborders-140-70
[{Image src='User/paper_content_pencil_48.png' width='48px' class='image_left'}]
[Curriculum Vitae |User/Cohen_Adam_Frederik/CV]
%%
----
%%coolborders-140-70
[{Image src='User/book_48.png' class='image_left'}]
[Publication list|User/Cohen_Adam_Frederik/Publications]
%%
----
%%coolborders-140-70
[{Image src='User/camera_noflash_48.png' width='48px' class='image_left'}]
[Highlights of my work and anecdotes|User/Cohen_Adam_Frederik/Highlight]
%%
----
%%coolborders-140-70
[{Image src='User/database_48.png' class='image_left'}]
[Other information|User/Cohen_Adam_Frederik/OtherInformation]
%%
%%

[{ALLOW view All}]
[{ALLOW edit acohen}]
[{ALLOW upload acohen}]
[{ALLOW comment All}]